Skip to main content
MAXCYTE, INC. logo

MAXCYTE, INC. — Investor Relations & Filings

Ticker · MXCT ISIN · US57777K1060 LEI · 54930053YHXULRFCU991 US Professional, scientific and technical activities
Open in API
Filings indexed 767 across all filing types
Latest filing 2023-06-23 Declaration of Voting R…
Country US United States of America
Listing US MXCT

About MAXCYTE, INC.

https://www.maxcyte.com/

MaxCyte, Inc. is a cell-engineering company that provides enabling platform technologies to advance the discovery, development, and commercialization of cell-based therapeutics. Its core offering is the ExPERT™ platform, which utilizes proprietary Flow Electroporation® technology for efficient, scalable, and non-viral transfection of complex cells. This technology supports a wide range of applications, including cell therapy, gene editing, antibody and protein production, and vaccine development. Additionally, MaxCyte offers SeQure™ genotoxicity assessment services to evaluate the safety of gene-edited products by detecting on- and off-target effects. The company employs a partnership-driven licensing model to support clients from early-stage research through to clinical and commercial manufacturing.

Recent filings

Filing Released Lang Actions
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement from MaxCyte, Inc. regarding the 'Result of AGM' (Annual General Meeting). It explicitly states that all resolutions were duly passed at the meeting held on June 22, 2023. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2023-06-23 English
Publication of Annual Report
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 5,000 characters) from MaxCyte, Inc. titled 'Publication of Annual Report'. It explicitly states that the company has published its Annual Report and provides a link to the company's website to view it. According to the 'Menu vs Meal' rule, this is an announcement of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2023-06-21 English
Exercise of options and PDMR dealing
Director's Dealing Classification · 1% confidence The document is an official notification of share transactions (exercise of options and subsequent sale of shares) by a Person Discharging Managerial Responsibilities (PDMR), specifically the CEO, Doug Doerfler. It includes detailed tables of transaction dates, volumes, and prices, which is the standard format for Director's Dealing disclosures under market abuse regulations. Therefore, it is classified as a Director's Dealing (DIRS).
2023-06-16 English
FORM 4 SUBMISSION
Director's Dealing
2023-06-15 English
Upcoming Investor Conferences
Regulatory Filings Classification · 1% confidence The document is a short announcement (under 5,000 characters) issued via RNS (Regulatory News Service) regarding the company's participation in upcoming investor conferences. It does not contain the actual presentation materials or financial reports, but rather serves as a notification of management's schedule. As it does not fit into specific categories like 'Investor Presentation' (which would contain the slides) or 'Earnings Release', it is classified as a general regulatory filing.
2023-06-02 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from MaxCyte, Inc. regarding 'Total Voting Rights'. It details the issuance of new common stock following the exercise of share options and provides the updated total issued share capital to be used by shareholders for regulatory notification calculations. This falls under the category of share capital changes and voting rights updates, which is best classified as SHA (Share Issue/Capital Change).
2023-06-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.